Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Cyst Fibros. 2015 Jul 10;15(4):518–530. doi: 10.1016/j.jcf.2015.06.005

Figure 6.

Figure 6

Clinical isolate time course inhibition assays for tobramycin/D-met combinations. Graphs show optical density plotted over time during bacterial log growth phase. Tobramycin (at MIC) was combined with serial D-met dilutions (6400–100 μg/ml) and compared to clinical isolate growth. Studies were performed in triplicate. D-met did not significantly inhibit antimicrobial efficacy (p ≤ 0.05). Clinical isolates tested were: A) E. coli; B) S. aureus; and C) P. aeruginosa.